Topical capsaicin cream provided modest pain relief for emergency department patients with suspected cannabinoid hyperemesis syndrome, with 42% needing no further treatment afterward.
Emergency medicine providers, cannabis users experiencing cyclical vomiting
42% needed no further therapy after capsaicin
What the researchers found
Among 57 patients receiving capsaicin for suspected CHS, pain scores dropped from a median of 8 to 5.5, and nearly half required no additional symptomatic therapy after application.
Why it matters
Cannabinoid hyperemesis syndrome is notoriously difficult to treat. Standard antiemetics often fail, and many patients receive opioids. A simple topical cream that provides relief could reduce reliance on more problematic medications.
The numbers in context
57 patients; pain score median 8 to 5.5; 98% received antiemetics; 47% received an opioid; 42% needed no further therapy after capsaicin; capsaicin applied at median 4 hours into visit
How the study worked
Retrospective chart review of 57 patients with suspected CHS who received capsaicin cream in an emergency department between July 2014 and October 2018.
What this study cannot tell us
Retrospective design without a control group. Capsaicin was typically given after antiemetics and opioids, making it hard to isolate its independent effect.
How to read the evidence
Retrospective chart review without a control group, and capsaicin was given after other treatments in most cases.
When this study was published
Published in 2022
The bigger picture
CHS has become increasingly common as cannabis use has risen. Finding effective non-opioid treatments for the severe abdominal pain it causes remains a clinical priority.
Questions still open
- Would earlier capsaicin application produce better results? Could capsaicin reduce the need for opioids if given as a first-line treatment for CHS?
Common questions
What is cannabinoid hyperemesis syndrome?
How does capsaicin cream help with CHS?
Read the original research
Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department.
The Annals of pharmacotherapy, 56(2), 151-154
Citation
Lee, Allison; Coralic, Zlatan. (2022). Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department.. The Annals of pharmacotherapy, 56(2), 151-154. https://doi.org/10.1177/10600280211018516
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk